Amanda Luck

746 total citations
19 papers, 558 citations indexed

About

Amanda Luck is a scholar working on Physiology, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Amanda Luck has authored 19 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 4 papers in Biomedical Engineering and 3 papers in Molecular Biology. Recurrent topics in Amanda Luck's work include Lysosomal Storage Disorders Research (7 papers), Ultrasound and Hyperthermia Applications (4 papers) and Biochemical Acid Research Studies (3 papers). Amanda Luck is often cited by papers focused on Lysosomal Storage Disorders Research (7 papers), Ultrasound and Hyperthermia Applications (4 papers) and Biochemical Acid Research Studies (3 papers). Amanda Luck collaborates with scholars based in Canada, United States and Australia. Amanda Luck's co-authors include James T. Rutka, Christian A. Smith, Kim M. Hemsley, Helen Beard, Sofia Hassiotis, John J. Hopwood, Kullervo Hynynen, Megan Wu, Meaghan A. O’Reilly and Daniel Coluccia and has published in prestigious journals such as Cancer Research, Scientific Reports and Journal of Controlled Release.

In The Last Decade

Amanda Luck

19 papers receiving 550 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Amanda Luck 208 168 139 99 86 19 558
Aurora Bernal 120 0.6× 140 0.8× 224 1.6× 188 1.9× 37 0.4× 18 683
Zion Zibly 287 1.4× 45 0.3× 183 1.3× 43 0.4× 90 1.0× 40 727
Francesca J. Nicholls 165 0.8× 93 0.6× 216 1.6× 50 0.5× 177 2.1× 11 806
Benjamin D. Gastfriend 210 1.0× 62 0.4× 384 2.8× 41 0.4× 58 0.7× 20 900
Chengyan Chu 245 1.2× 40 0.2× 250 1.8× 136 1.4× 127 1.5× 39 888
Heather M. Ames 68 0.3× 79 0.5× 411 3.0× 155 1.6× 42 0.5× 27 811
Karl Rouger 82 0.4× 116 0.7× 400 2.9× 149 1.5× 39 0.5× 35 623
Erwin Gorjup 148 0.7× 49 0.3× 215 1.5× 152 1.5× 56 0.7× 15 513
Hannah Taylor 80 0.4× 40 0.2× 262 1.9× 71 0.7× 66 0.8× 17 498

Countries citing papers authored by Amanda Luck

Since Specialization
Citations

This map shows the geographic impact of Amanda Luck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Luck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Luck more than expected).

Fields of papers citing papers by Amanda Luck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Luck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Luck. The network helps show where Amanda Luck may publish in the future.

Co-authorship network of co-authors of Amanda Luck

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Luck. A scholar is included among the top collaborators of Amanda Luck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Luck. Amanda Luck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Luck, Amanda, et al.. (2025). Preclinical evaluation of DC-CIK cells as potentially effective immunotherapy model for the treatment of glioblastoma. Scientific Reports. 15(1). 734–734. 3 indexed citations
2.
Golbourn, Brian, Ben Ho, Amanda Luck, et al.. (2024). A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors. Neuro-Oncology. 26(10). 1895–1911. 2 indexed citations
3.
Simões, Sérgio, Joji Ishida, Michael S. Taccone, et al.. (2024). Combination treatment with histone deacetylase and carbonic anhydrase 9 inhibitors shows therapeutic potential in experimental diffuse intrinsic pontine glioma. Brain Tumor Pathology. 41(3-4). 117–131. 1 indexed citations
4.
Wong, Raymond, Amanda Luck, N. Sabha, et al.. (2020). Inhibition of TRPM7 with waixenicin A reduces glioblastoma cellular functions. Cell Calcium. 92. 102307–102307. 18 indexed citations
5.
Ishida, Joji, Saira Alli, Brian Golbourn, et al.. (2020). MRI-guided focused ultrasound enhances drug delivery in experimental diffuse intrinsic pontine glioma. Journal of Controlled Release. 330. 1034–1045. 50 indexed citations
6.
Diaz, Roberto J., Amanda Luck, Brian Golbourn, et al.. (2018). Characterization of a Clival Chordoma Xenograft Model Reveals Tumor Genomic Instability. American Journal Of Pathology. 188(12). 2902–2911. 7 indexed citations
7.
Coluccia, Daniel, Megan Wu, Alexandra N. Riemenschneider, et al.. (2018). Enhancing glioblastoma treatment using cisplatin-gold-nanoparticle conjugates and targeted delivery with magnetic resonance-guided focused ultrasound. Nanomedicine Nanotechnology Biology and Medicine. 14(4). 1137–1148. 118 indexed citations
8.
Alli, Saira, Brian Golbourn, N. Sabha, et al.. (2018). Brainstem blood brain barrier disruption using focused ultrasound: A demonstration of feasibility and enhanced doxorubicin delivery. Journal of Controlled Release. 281. 29–41. 115 indexed citations
9.
Alli, Saira, N. Sabha, Megan Wu, et al.. (2017). PDTM-33. FOCUSED ULTRASOUND DISRUPTION OF THE BLOOD BRAIN BARRIER IN THE BRAINSTEM: A FEASIBILITY AND SAFETY STUDY. Neuro-Oncology. 19(suppl_6). vi197–vi197. 1 indexed citations
10.
Winner, Leanne K., Helen Beard, Sofia Hassiotis, et al.. (2016). A Preclinical Study Evaluating AAVrh10-Based Gene Therapy for Sanfilippo Syndrome. Human Gene Therapy. 27(5). 363–375. 37 indexed citations
11.
Beard, Helen, Amanda Luck, Sofia Hassiotis, et al.. (2015). Determination of the role of injection site on the efficacy of intra-CSF enzyme replacement therapy in MPS IIIA mice. Molecular Genetics and Metabolism. 115(1). 33–40. 26 indexed citations
12.
Beard, Helen, Sofia Hassiotis, Amanda Luck, et al.. (2015). Continual Low-Dose Infusion of Sulfamidase Is Superior to Intermittent High-Dose Delivery in Ameliorating Neuropathology in the MPS IIIA Mouse Brain. JIMD Reports. 29. 59–68. 7 indexed citations
13.
Golbourn, Brian, et al.. (2015). Abstract 4038: Role of the Rho-GTPase CDC42 in glioma migration. Cancer Research. 75(15_Supplement). 4038–4038. 1 indexed citations
14.
Hassiotis, Sofia, Helen Beard, Amanda Luck, et al.. (2014). Disease stage determines the efficacy of treatment of a paediatric neurodegenerative disease. European Journal of Neuroscience. 39(12). 2139–2150. 15 indexed citations
15.
Rutka, James T., Jin Bong Park, Brian Golbourn, et al.. (2014). TRANSCRIPTIONAL PROFILING OF GBM INVASIVE GENES IDENTIFIES EFFECTIVE INHIBITORS OF THE LIM KINASE-COFILIN PATHWAY. Neuro-Oncology. 16(suppl 3). iii34–iii34. 3 indexed citations
16.
Park, Jun-Bum, Sameer Agnihotri, Brian Golbourn, et al.. (2014). Transcriptional profiling of GBM invasion genes identifies effective inhibitors of the LIM kinase-Cofilin pathway. Oncotarget. 5(19). 9382–9395. 40 indexed citations
17.
Rozaklis, Tina, Helen Beard, Sofia Hassiotis, et al.. (2011). Impact of high-dose, chemically modified sulfamidase on pathology in a murine model of MPS IIIA. Experimental Neurology. 230(1). 123–130. 37 indexed citations
18.
Lau, Adeline A., Tina Rozaklis, Sandy Ibanes, et al.. (2011). Helper-dependent canine adenovirus vector-mediated transgene expression in a neurodegenerative lysosomal storage disorder. Gene. 491(1). 53–57. 19 indexed citations
19.
Hemsley, Kim M., Amanda Luck, Allison C. Crawley, et al.. (2009). Examination of intravenous and intra‐CSF protein delivery for treatment of neurological disease. European Journal of Neuroscience. 29(6). 1197–1214. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026